迪戈辛在心房的坏名声 - 因果关系还是偏见? 全国嵌的病例控制研究
Anders Holt1, Jarl Emanuel Strange1, Morten Lock Hansen1
1Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.
American journal of medicine open
|April 1, 2025
概括
在心房动 (AF) 患者中使用digoxin显示死亡率增加. 然而,这种关联可能不是因果关系,因为狄戈辛的使用也与负对照结果相关,这表明它表明了患者的脆弱性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 以前的研究表明,在心房动 (AF) 患者中,与狄戈辛相关的死亡风险增加.
- 目前的研究旨在验证这些发现,并探索潜在的混因素,如偏见.
研究的目的:
- 研究心房动 (AF) 患者的狄戈辛使用与死亡率之间的关联.
- 用负对照结果来确定观察到的关联是否因果关系或可能被偏见解释.
主要方法:
- 在2012年至2022年期间,使用丹麦全国性注册表进行了一项嵌套病例控制研究.
- 病例被定义为死于任何原因,与比塔-阻断剂/维拉帕米尔相比,暴露于迪戈辛.
- 负对照结果,如养老院入院,被用来评估偏见.
主要成果:
- 迪戈辛的使用与整体AF队列 (HR 1.85) 和包括心力衰竭,糖尿病和脏疾病在内的子组的死亡率增加有关.
- 还观察到狄戈辛使用与负对照结果之间存在显著的关联,包括养老院入院 (HR 1.79).
结论:
- 虽然狄戈辛的使用与AF患者的死亡率增加有关,但与负对照结果的同时关联表明这种关系可能不是因果关系.
- 迪戈辛的处方可以作为更先进的疾病和患者虚弱的标记,而不是直接导致死亡的原因.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
670
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
670
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
850
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
850
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
719
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
719
Heart Failure Drugs: Inotropic Agents
445
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
445
Causality in Epidemiology
190
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
190


